70 related articles for article (PubMed ID: 29408595)
1. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
Nan H; Han L; Ma J; Yang C; Su R; He J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
[TBL] [Abstract][Full Text] [Related]
2. Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway.
Martinez JD; Mo Q; Xu Y; Qin L; Li Y; Xu J
Int J Biol Sci; 2022; 18(1):229-241. PubMed ID: 34975329
[TBL] [Abstract][Full Text] [Related]
3. Correlation of PTEN signaling pathway and miRNA in breast cancer.
Mohammadi M; Fazilat A; Mamalo AS; Ojarudi M; Hemmati-Dinarvand M; Beilankouhi EAV; Valilo M
Mol Biol Rep; 2024 Jan; 51(1):221. PubMed ID: 38281224
[TBL] [Abstract][Full Text] [Related]
4. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade.
Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
[TBL] [Abstract][Full Text] [Related]
5. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo.
Chiang KC; Chen HY; Hsu SY; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Sun CC; Lee JM; Yeh CN; Juang HH
Drug Des Devel Ther; 2015; 9():4631-8. PubMed ID: 26316702
[TBL] [Abstract][Full Text] [Related]
6. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.
Wu J; Wen T; Marzio A; Song D; Chen S; Yang C; Zhao F; Zhang B; Zhao G; Ferri A; Cheng H; Ma J; Ren H; Chen QY; Yang Y; Qin S
Cell Death Dis; 2024 Apr; 15(4):282. PubMed ID: 38643215
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer.
Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
[TBL] [Abstract][Full Text] [Related]
8. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
9. The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
Golden E; Rashwan R; Woodward EA; Sgro A; Wang E; Sorolla A; Waryah C; Tie WJ; Cuyàs E; Ratajska M; Kardaś I; Kozlowski P; Johnstone EKM; See HB; Duffy C; Parry J; Lagerborg KA; Czapiewski P; Menendez JA; Gorczyński A; Wasag B; Pfleger KDG; Curtis C; Lee BK; Kim J; Cursons J; Pavlos NJ; Biernat W; Jain M; Woo AJ; Redfern A; Blancafort P
Nat Commun; 2021 Mar; 12(1):1920. PubMed ID: 33772001
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
Saal LH; Johansson P; Holm K; Gruvberger-Saal SK; She QB; Maurer M; Koujak S; Ferrando AA; Malmström P; Memeo L; Isola J; Bendahl PO; Rosen N; Hibshoosh H; Ringnér M; Borg A; Parsons R
Proc Natl Acad Sci U S A; 2007 May; 104(18):7564-9. PubMed ID: 17452630
[TBL] [Abstract][Full Text] [Related]
11. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller KA; Degan S; Wang Y; Cohen J; Ku SY; Goodrich DW; Gelman IH
Oncogene; 2024 Jan; 43(1):22-34. PubMed ID: 37875657
[TBL] [Abstract][Full Text] [Related]
12. eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.
Treekitkarnmongkol W; Solis LM; Sankaran D; Gagea M; Singh PK; Mistry R; Nguyen T; Kai K; Liu J; Sasai K; Jitsumori Y; Liu J; Nagao N; Stossi F; Mancini MA; Wistuba II; Thompson AM; Lee JM; Cadiñanos J; Wong KK; Abbott CM; Sahin AA; Liu S; Katayama H; Sen S
Sci Signal; 2024 Mar; 17(826):eadh4475. PubMed ID: 38442201
[TBL] [Abstract][Full Text] [Related]
13. Potential Site Effects and Transgene Expression Discrepancies in Mouse Lifespan Studies.
Thurmond DC; Oh E; Miller RA
Cell Metab; 2015 Sep; 22(3):346-7. PubMed ID: 26331599
[No Abstract] [Full Text] [Related]
14. Acrylamide alters CREB and retinoic acid signalling pathways during differentiation of the human neuroblastoma SH-SY5Y cell line.
Attoff K; Johansson Y; Cediel-Ulloa A; Lundqvist J; Gupta R; Caiment F; Gliga A; Forsby A
Sci Rep; 2020 Oct; 10(1):16714. PubMed ID: 33028897
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.
Yin L; Xu Y; Yin J; Cheng H; Xiao W; Wu Y; Ji D; Gao S
Front Mol Neurosci; 2023; 16():1304224. PubMed ID: 38115820
[TBL] [Abstract][Full Text] [Related]
16. Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients.
Shinozuka T; Kanda M; Sato Y; Shimizu D; Tanaka C; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Cancer Med; 2023 Dec; 12(24):22185-22195. PubMed ID: 38014487
[TBL] [Abstract][Full Text] [Related]
17. Identification of key gene signatures for the overall survival of ovarian cancer.
Pawar A; Chowdhury OR; Chauhan R; Talole S; Bhattacharjee A
J Ovarian Res; 2022 Jan; 15(1):12. PubMed ID: 35057823
[TBL] [Abstract][Full Text] [Related]
18. circPTEN suppresses colorectal cancer progression through regulating PTEN/AKT pathway.
Li C; Li X
Mol Ther Nucleic Acids; 2021 Dec; 26():1418-1432. PubMed ID: 34938598
[TBL] [Abstract][Full Text] [Related]
19. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.
Li P; Song R; Yin F; Liu M; Liu H; Ma S; Jia X; Lu X; Zhong Y; Yu L; Li X; Li X
Mol Ther; 2022 Jan; 30(1):431-447. PubMed ID: 34450251
[TBL] [Abstract][Full Text] [Related]
20. The predictive prognostic values of
Chen Y; Shen L; Chen B; Han X; Yu Y; Yuan X; Zhong L
Ann Transl Med; 2021 May; 9(10):843. PubMed ID: 34164477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]